首页> 外文期刊>Journal of biomedical optics >Complete blood vessel occlusion in the chick chorioallantoic membrane using two-photon excitation photodynamic therapy: implications for treatment of wet age-related macular degeneration
【24h】

Complete blood vessel occlusion in the chick chorioallantoic membrane using two-photon excitation photodynamic therapy: implications for treatment of wet age-related macular degeneration

机译:双光子激发光动力疗法在鸡绒囊尿囊膜中完全阻塞血管:对湿性年龄相关性黄斑变性的治疗意义

获取原文
获取原文并翻译 | 示例
       

摘要

Complete blood vessel occlusion is required for the treatment of age-related macular degeneration (AMD). AMD is the leading cause of blindness in developed countries and current treatment regimes have potential to cause collateral damage, or do not remove pre-existing unwanted vasculature. It has been proposed that two-photon excitation (TPE) photodynamic therapy (PDT) can be applied to cause local blood vessel occlusion without damaging surrounding retinal tissues. The in ovo chicken chorioallantoic membrane (CAM) is used as the model for vascularization in the wet form of AMD; novel techniques for the utilization of the CAM are reported. Complete occlusion of CAM vessels ~15 μm in diameter is achieved using the clinically approved photosensitizer Verteporfin (Visudyne~®, QLT, Incorporated, Vancouver, British Columbia, Canada) and TPE activation. The average and peak irradiances used for treatment are 3.3×10~6 W/cm~2 and 3.7×10~(11) W/cm~2, respectively. A total flu-ence of 1.1×10~8 J/cm~2 is the dosage required for successful occlusion, and it is expected that for optimal conditions it will be much less. These results are the first proof-of-principle evidence in the literature that indicate TPE-PDT can be used to occlude small blood vessels. Further investigation will help determine the utility of TPE-PDT for treating wet AMD, perhaps through targeting feeder vessels.
机译:治疗年龄相关性黄斑变性(AMD)需要完全闭塞血管。在发达国家,AMD是导致失明的主要原因,当前的治疗方案有可能造成附带损害,或无法消除原有的有害血管。已经提出,可以应用双光子激发(TPE)光动力疗法(PDT)来引起局部血管闭塞而不损害周围的视网膜组织。卵内鸡尿囊尿膜(CAM)用作AMD湿润形式的血管化模型;报告了利用CAM的新技术。使用临床认可的光敏剂Verteporfin(Visudyne?®,QLT,Incorporated,Vancouver,不列颠哥伦比亚省,加拿大)和TPE活化可完全堵塞直径约15μm的CAM血管。用于治疗的平均辐照度和峰值辐照度分别为3.3×10〜6 W / cm〜2和3.7×10〜(11)W / cm〜2。总通量为1.1×10〜8 J / cm〜2是成功闭塞所需的剂量,并且预计在最佳条件下它将大大降低。这些结果是文献中的第一个原理证明,表明TPE-PDT可用于阻塞小血管。进一步的研究将有助于确定TPE-PDT在治疗湿性AMD中的实用性,也许可以通过靶向给料血管来进行。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号